BioStock: Cyxone joins forces with leading rheumatoid arthritis expert
Biotech company Cyxone is in the process of preparing drug candidate Rabeximod for the next clinical stage. Recently, the company announced a collaboration with Professor Costantino Pitzalis, a world leading expert redefining clinical trial design in RA, to advise on the upcoming phase IIb trial. BioStock reached out to professor Pitzalis to hear his view on Rabeximod and what impact the drug candidate potentially can make in the field of rheumatoid arthritis in the current market.
Read the full interview with Professor Costantino Pitzalis at biostock.se:
This is a pressrelease from BioStock Connecting Innovation & Capital. https://www.biostock.se/
NOTICE TO ANNUAL GENERAL MEETING IN BRIGHTER AB (PUBL)
Notice of attendance shall be made in writing to Brighter AB (publ), Borgarfjordsgatan 18, 164 40 Kista or by email to [email protected] On giving notice of attendance, the shareholder should state the shareholder’s name, personal identity number or equivalent /corporate identity number, address...
Bronson Methodist Hospital implements WasteLog®
Bronson Methodist Hospital is a 434-bed teaching hospital and trauma center located in central Kalamazoo, Michigan. Bronson Methodist Hospital is the flagship of the Bronson Healthcare Group, a nonprofit healthcare system with a total of four hospitals located in southwest Michigan and northern Indi...
Bronson Methodist Hospital beställer WasteLog®
Bronson Methodist Hospital är ett undervisningssjukhus och traumacenter med totalt 424 vårdplatser beläget i centrala Kalamazoo, Michigan. Bronson Methodist Hospital är flaggskeppet för Bronson Healthcare Group, ett ideellt sjukvårdssystem som har totalt fyra sjukhus...